AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32300013 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief video-based training for teachers to change language used to introduce science.
Number of subjects: 1100
Study 32300013 — intervention group
Group type: COMPARATOR
Intervention: Baseline control condition where teachers described scientists as a special kind of person.
Number of subjects: 1100
Study 35277773 — intervention group
Group type: EXPERIMENTAL
Intervention: STAR intervention (text messaging reminders)
Number of subjects: 35
Study 35277773 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard post-operative education)
Number of subjects: 35
Study 33416214 — intervention group
Group type: EXPERIMENTAL
Intervention: Survivorship care plan (SCP) plus mobile app
Number of subjects: 224
Study 33416214 — intervention group
Group type: COMPARATOR
Intervention: Survivorship care plan (SCP) only
Number of subjects: 224
Study 33416214 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile app
Number of subjects: 224
Study 36047732 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time, electronic alert-triggered, patient-centered education bundle
Number of subjects: 11098
Study 36047732 — intervention group
Group type: COMPARATOR
Intervention: Nurse feedback intervention
Number of subjects: 11098
Study 33994084 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar plate group
Number of subjects: 62
Study 33994084 — intervention group
Group type: COMPARATOR
Intervention: External fixator group
Number of subjects: 62
Study 35663978 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant trastuzumab and pertuzumab treatment
Number of subjects: 159
Study 35663978 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined prediction model using HER2/CEP17 ratio, CD8 levels, and histological grade
Number of subjects: 159
Study 33691266 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory Flexibility (MemFlex) intervention
Number of subjects: 74
Study 33691266 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation about cognitive-behavioral mechanisms
Number of subjects: 74
Study 35274092 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose azathioprine (median dose 50 mg) combined with allopurinol (100 mg)
Number of subjects: 89
Study 35274092 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine monotherapy (median dose 200 mg)
Number of subjects: 89
Study 35274092 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose azathioprine combined with allopurinol
Number of subjects: 89
Study 35274092 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine monotherapy
Number of subjects: 89
Study 33901566 — intervention group
Group type: EXPERIMENTAL
Intervention: ADT + DERT76
Number of subjects: 600
Study 33901566 — intervention group
Group type: EXPERIMENTAL
Intervention: ADT + RT70
Number of subjects: 600
Study 33901566 — intervention group
Group type: COMPARATOR
Intervention: DERT76
Number of subjects: 600
Study 33726766 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 663
Study 33726766 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 663
Study 32636292 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate skin-to-skin contact (SSC) with a parent
Number of subjects: 150
Study 32636292 — intervention group
Group type: COMPARATOR
Intervention: Conventional care in an incubator
Number of subjects: 150
Study 34719982 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional citrate anticoagulation (RCA)
Number of subjects: 31
Study 34719982 — intervention group
Group type: COMPARATOR
Intervention: No anticoagulation (NA)
Number of subjects: 31
Study 32444401 — intervention group
Group type: EXPERIMENTAL
Intervention: As-needed budesonide-formoterol (200/6 μg Turbuhaler, one actuation)
Number of subjects: 110
Study 32444401 — intervention group
Group type: COMPARATOR
Intervention: Maintenance budesonide (200 μg Turbuhaler, one actuation twice a day) with as-needed terbutaline (250 μg, two actuations)
Number of subjects: 110
Study 32444401 — intervention group
Group type: EXPERIMENTAL
Intervention: As-needed budesonide-formoterol
Number of subjects: 110
Study 34490700 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec U100
Number of subjects: 180
Study 34490700 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine U100
Number of subjects: 180
Study 32462206 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Body Firming Moisturizer (TBFM) applied twice daily for 12 weeks
Number of subjects: 40
Study 32462206 — intervention group
Group type: COMPARATOR
Intervention: Placebo moisturizer applied twice daily for 12 weeks
Number of subjects: 40
Study 32991650 — intervention group
Group type: COMPARATOR
Intervention: SAC Assessment Tool used by control dentist
Number of subjects: 30
Study 32991650 — intervention group
Group type: EXPERIMENTAL
Intervention: SAC Assessment Tool used by dentists 1, 2, and 3
Number of subjects: 30
Study 32991650 — intervention group
Group type: COMPARATOR
Intervention: No SAC Assessment Tool used by control dentist
Number of subjects: 30
Study 32991650 — intervention group
Group type: EXPERIMENTAL
Intervention: No SAC Assessment Tool used by dentists 1, 2, and 3
Number of subjects: 30
Study 33278832 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin (GFR ≥ 45–59)
Number of subjects: 56034
Study 33278832 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin (GFR < 45)
Number of subjects: 56034
Study 33278832 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin (ARISTOTLE and ENGAGE trials, GFR ≥ 45–59)
Number of subjects: 56034
Study 33278832 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin (ARISTOTLE and ENGAGE trials, GFR < 45)
Number of subjects: 56034
Study 33278832 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran (GFR ≥ 45–59)
Number of subjects: 56034
Study 33278832 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran (GFR < 45)
Number of subjects: 56034
Study 33278832 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran (GFR < 60)
Number of subjects: 56034
Study 33278832 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban (GFR ≥ 45–59)
Number of subjects: 56034
Study 33278832 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban (GFR < 45)
Number of subjects: 56034
Study 33278832 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban (GFR < 60)
Number of subjects: 56034
Study 33278832 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban (GFR ≥ 45–59)
Number of subjects: 56034
Study 33278832 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban (GFR < 45)
Number of subjects: 56034
Study 33278832 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban and Edoxaban (GFR ≥ 45–59)
Number of subjects: 56034
Study 33278832 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban and Edoxaban (GFR < 45)
Number of subjects: 56034
Study 32513646 — intervention group
Group type: EXPERIMENTAL
Intervention: HappyAir group (mHealth web-based platform)
Number of subjects: 44
Study 32513646 — intervention group
Group type: COMPARATOR
Intervention: Control group (scheduled check-ups)
Number of subjects: 44
Study 34854112 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% metronidazole gel
Number of subjects: 130
Study 34854112 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 130
Study 33600014 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT (n = 26)
Number of subjects: 40
Study 33600014 — intervention group
Group type: COMPARATOR
Intervention: CON (n = 14)
Number of subjects: 40
Study 33085861 — intervention group
Group type: EXPERIMENTAL
Intervention: AK002 (combined low-dose and high-dose)
Number of subjects: 65
Study 33085861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 35077261 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid initiation of CPB (15 seconds)
Number of subjects: 0
Study 35077261 — intervention group
Group type: COMPARATOR
Intervention: Slow initiation of CPB (180 seconds)
Number of subjects: 0
Study 32873104 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical Thrombectomy (MT)
Number of subjects: 100
Study 32599071 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus chemotherapy
Number of subjects: 559
Study 32599071 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus chemotherapy
Number of subjects: 559
Study 34004416 — intervention group
Group type: EXPERIMENTAL
Intervention: ResistAid (15 g/d)
Number of subjects: 30
Study 34004416 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin (control, 15 g/d)
Number of subjects: 30
Study 36336861 — intervention group
Group type: EXPERIMENTAL
Intervention: Single high oral dose of vitamin D3 (120,000 IU)
Number of subjects: 58
Study 34082737 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective communication skills training (7 sessions of 45 min each)
Number of subjects: 94
Study 34082737 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 94
Study 32859032 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glutamate diet
Number of subjects: 40
Study 32859032 — intervention group
Group type: COMPARATOR
Intervention: Monosodium glutamate (MSG)/placebo
Number of subjects: 40
Study 33616612 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilotinib
Number of subjects: 0
Study 32404181 — intervention group
Group type: EXPERIMENTAL
Intervention: Height-adjustable workstation
Number of subjects: 58
Study 32404181 — intervention group
Group type: EXPERIMENTAL
Intervention: Education seminar
Number of subjects: 58
Study 32404181 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback on sitting time
Number of subjects: 58
Study 32404181 — intervention group
Group type: EXPERIMENTAL
Intervention: Darma cushion
Number of subjects: 58
Study 32404181 — intervention group
Group type: EXPERIMENTAL
Intervention: Action planning/goal setting diary
Number of subjects: 58
Study 32404181 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall benefits
Number of subjects: 58
Study 32404181 — intervention group
Group type: COMPARATOR
Intervention: Control group feedback
Number of subjects: 58
Study 35991134 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized nursing
Number of subjects: 40
Study 35991134 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing
Number of subjects: 40
Study 33805193 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio tape (KT) applied to 20 patients (21 elbows)
Number of subjects: 50
Study 33805193 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid injection (CSI) applied to 15 patients (17 elbows)
Number of subjects: 50
Study 33805193 — intervention group
Group type: COMPARATOR
Intervention: Rest-and-medication group (RMG) with 15 patients
Number of subjects: 50
Study 32619050 — intervention group
Group type: EXPERIMENTAL
Intervention: Super-mini PCNL (SMP)
Number of subjects: 150
Study 32619050 — intervention group
Group type: COMPARATOR
Intervention: Standard percutaneous nephrolithotomy (sPCNL)
Number of subjects: 150
Study 34941287 — intervention group
Group type: EXPERIMENTAL
Intervention: Live Healthy, Work Healthy (LHWH) program
Number of subjects: 0
Study 34669318 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic Magnesium supplementation (oral for 5 days before surgery)
Number of subjects: 120
Study 34669318 — intervention group
Group type: COMPARATOR
Intervention: Control group (received Magnesium only after evidence of postoperative hypomagnesemia)
Number of subjects: 120
Study 34669318 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (postoperative Calcium and Magnesium administered to all patients with hypocalcemia and hypomagnesemia)
Number of subjects: 120
Study 34669318 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis between Magnesium, Calcium, and parathyroid hormone
Number of subjects: 120
Study 36327536 — intervention group
Group type: EXPERIMENTAL
Intervention: Medially‐posted foot orthosis
Number of subjects: 53
Study 36327536 — intervention group
Group type: COMPARATOR
Intervention: Flat insert (sham orthosis)
Number of subjects: 53
Study 36327536 — intervention group
Group type: COMPARATOR
Intervention: Everyday‐shoe insole (baseline)
Number of subjects: 53
Study 33003044 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrolyte hydration intervention during 2 of the 3 weeks
Number of subjects: 50
Study 36328094 — intervention group
Group type: EXPERIMENTAL
Intervention: CHARM2 intervention
Number of subjects: 1201
Study 36328094 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1201
Study 33988725 — intervention group
Group type: EXPERIMENTAL
Intervention: Tradipitant 85 mg/bid
Number of subjects: 8
Study 33988725 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone (0 to 30 mg)
Number of subjects: 8
Study 32565318 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant and concurrent ADT for 6 months starting 4 months before prostate radiation therapy (NHT arm)
Number of subjects: 0
Study 32565318 — intervention group
Group type: COMPARATOR
Intervention: Concurrent and adjuvant ADT for 6 months starting simultaneously with radiation therapy (CAHT arm)
Number of subjects: 0
Study 32565318 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms (NHT and CAHT)
Number of subjects: 0
Study 34215673 — intervention group
Group type: EXPERIMENTAL
Intervention: 68Ga-satoreotide trizoxetan at a peptide mass of 5-20 µg and 30-45 µg with radioactivity ranges of 40-80, 100-140, or 160-200 MBq
Number of subjects: 24
Study 34215673 — intervention group
Group type: EXPERIMENTAL
Intervention: 68Ga-satoreotide trizoxetan PET/CT
Number of subjects: 24
Study 34215673 — intervention group
Group type: COMPARATOR
Intervention: Radioactivity range of 40-80 MBq
Number of subjects: 24
Study 34215673 — intervention group
Group type: EXPERIMENTAL
Intervention: 68Ga-satoreotide trizoxetan
Number of subjects: 24
Study 34419676 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid photodynamic therapy (5-ALA-PDT)
Number of subjects: 36
Study 34419676 — intervention group
Group type: COMPARATOR
Intervention: Wide local excision (WLE)
Number of subjects: 36
Study 35929816 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative wound packing
Number of subjects: 433
Study 35929816 — intervention group
Group type: COMPARATOR
Intervention: Non-packing
Number of subjects: 433
Study 35929816 — intervention group
Group type: EXPERIMENTAL
Intervention: Packing
Number of subjects: 433
Study 33185380 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin-treated group
Number of subjects: 80
Study 33185380 — intervention group
Group type: COMPARATOR
Intervention: Aspirin-naive group
Number of subjects: 80
Study 35802849 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton craniospinal irradiation (pCSI)
Number of subjects: 63
Study 35802849 — intervention group
Group type: COMPARATOR
Intervention: Photon involved-field radiotherapy (IFRT)
Number of subjects: 63
Study 35802849 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory pCSI group
Number of subjects: 63
Study 33411779 — intervention group
Group type: EXPERIMENTAL
Intervention: Calm app (mindfulness meditation mobile app), used for ≥10 minutes/day for eight weeks
Number of subjects: 263
Study 33411779 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 263
Study 35607454 — intervention group
Group type: COMPARATOR
Intervention: Normobaric hypoxia (NH)
Number of subjects: 16
Study 35607454 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter inter-set rest periods (60 s)
Number of subjects: 16
Study 35607454 — intervention group
Group type: COMPARATOR
Intervention: Hypobaric hypoxia (HH)
Number of subjects: 16
Study 32799920 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month community-based lifestyle intervention including group nutrition and health education classes (1 day/week) and group exercise classes (2 days/week)
Number of subjects: 117
Study 32799920 — intervention group
Group type: COMPARATOR
Intervention: Usual care control arm
Number of subjects: 117
Study 32799920 — intervention group
Group type: COMPARATOR
Intervention: Community recruitment
Number of subjects: 117
Study 32799920 — intervention group
Group type: COMPARATOR
Intervention: Clinical recruitment
Number of subjects: 117
Study 32799920 — intervention group
Group type: COMPARATOR
Intervention: Media recruitment
Number of subjects: 117
Study 35130937 — intervention group
Group type: EXPERIMENTAL
Intervention: New Orleans Intervention Model (NIM)
Number of subjects: 390
Study 35130937 — intervention group
Group type: COMPARATOR
Intervention: Optimised services as usual (SAU)
Number of subjects: 390
Study 32122727 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Level Laser Therapy (LLLT)
Number of subjects: 62
Study 32122727 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 62
Study 34851451 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic transcanal tympanoplasty with attico‐antrostomy
Number of subjects: 40
Study 34851451 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic-assisted canal wall up mastoidectomy
Number of subjects: 40
Study 33610513 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-treated colostrum (60 °C, 60 min)
Number of subjects: 10
Study 33610513 — intervention group
Group type: COMPARATOR
Intervention: Raw colostrum
Number of subjects: 10
Study 33610513 — intervention group
Group type: EXPERIMENTAL
Intervention: Colostrum feeding (both groups)
Number of subjects: 10
Study 33142541 — intervention group
Group type: EXPERIMENTAL
Intervention: Organic zinc (zinc amino acid complex) at low (35 mg/kg) and high (70 mg/kg) levels
Number of subjects: 720
Study 33142541 — intervention group
Group type: EXPERIMENTAL
Intervention: Inorganic zinc (zinc sulfate) at low (35 mg/kg) and high (70 mg/kg) levels
Number of subjects: 720
Study 33142541 — intervention group
Group type: COMPARATOR
Intervention: Control group without supplementary zinc
Number of subjects: 720
Study 33142541 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental zinc (both organic and inorganic)
Number of subjects: 720
Study 36423745 — intervention group
Group type: EXPERIMENTAL
Intervention: ctDNA surveillance with pembrolizumab
Number of subjects: 161
Study 36423745 — intervention group
Group type: COMPARATOR
Intervention: Observation (control)
Number of subjects: 161
Study 32602162 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 weeks of daily Internet gaming
Number of subjects: 104
Study 32602162 — intervention group
Group type: COMPARATOR
Intervention: Regular gamers
Number of subjects: 104
Study 33198538 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated student performances at four scripted standards: clear fail (CF), borderline (BD), clear pass (CPX), good (GD)
Number of subjects: 120
Study 32142507 — intervention group
Group type: EXPERIMENTAL
Intervention: Step It Up intervention (5-minute face-to-face discussion, written materials, pedometer, and step chart)
Number of subjects: 1007
Study 32142507 — intervention group
Group type: EXPERIMENTAL
Intervention: Step It Up intervention
Number of subjects: 1007
Study 34949506 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1000 mg, 20 mL) administered intravenously 10 min before surgery
Number of subjects: 66
Study 34949506 — intervention group
Group type: COMPARATOR
Intervention: Control (normal saline, 20 mL) administered intravenously
Number of subjects: 66
Study 32516229 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodesign Surgisis anal fistula plug
Number of subjects: 304
Study 32516229 — intervention group
Group type: COMPARATOR
Intervention: Surgeon's preference (advancement flap, cutting seton, fistulotomy, Ligation of the Intersphincteric Fistula Tract procedure)
Number of subjects: 304
Study 32516229 — intervention group
Group type: COMPARATOR
Intervention: Surgeon's preference
Number of subjects: 304
Study 34462287 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab and ipilimumab
Number of subjects: 605
Study 34462287 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (cisplatin or carboplatin plus pemetrexed)
Number of subjects: 605
Study 33430948 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 7044
Study 33430948 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7044
Study 34942224 — intervention group
Group type: EXPERIMENTAL
Intervention: cCBT + TAU
Number of subjects: 80
Study 34942224 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 80
Study 33639233 — intervention group
Group type: EXPERIMENTAL
Intervention: POPSAVEIT scoring system
Number of subjects: 355
Study 33639233 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors identified in multivariable analysis
Number of subjects: 355
Study 35007887 — intervention group
Group type: EXPERIMENTAL
Intervention: 6MWT10
Number of subjects: 27
Study 35007887 — intervention group
Group type: EXPERIMENTAL
Intervention: 6MWTF8
Number of subjects: 27
Study 35007887 — intervention group
Group type: COMPARATOR
Intervention: 6MWT30
Number of subjects: 27
Study 32872001 — intervention group
Group type: EXPERIMENTAL
Intervention: CRS followed by HIPEC (CRS+HIPEC; n=14)
Number of subjects: 28
Study 32872001 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided HIPEC followed by delayed CRS (HIPEC+dCRS; n=14)
Number of subjects: 28
Study 32898921 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group receiving predefined feedback between the two intubations
Number of subjects: 35
Study 32898921 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving no feedback
Number of subjects: 35
Study 32898921 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study 33772118 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal treatment
Number of subjects: 48
Study 33772118 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 48
Study 32444573 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training (RAGT) for 5 weeks (3 sessions per week)
Number of subjects: 16
Study 32444573 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) for 5 weeks
Number of subjects: 16
Study 34325236 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery enhanced cognitive restructuring (I-CR)
Number of subjects: 87
Study 34325236 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional cognitive restructuring (CR)
Number of subjects: 87
Study 34325236 — intervention group
Group type: COMPARATOR
Intervention: Active control (AC)
Number of subjects: 87
Study 36195164 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraurethral prilocaine solution
Number of subjects: 128
Study 36195164 — intervention group
Group type: COMPARATOR
Intervention: Intraurethral lidocaine gel
Number of subjects: 128